nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—SLC6A3—Gilles de la Tourette syndrome	0.365	0.431	CbGaD
Maprotiline—DRD2—Gilles de la Tourette syndrome	0.272	0.321	CbGaD
Maprotiline—HTR2A—Gilles de la Tourette syndrome	0.21	0.248	CbGaD
Maprotiline—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00567	0.112	CbGeAlD
Maprotiline—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00547	0.108	CbGeAlD
Maprotiline—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00341	0.0674	CbGeAlD
Maprotiline—Sertraline—SLC6A3—Gilles de la Tourette syndrome	0.00233	0.406	CrCbGaD
Maprotiline—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00166	0.0329	CbGeAlD
Maprotiline—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.0016	0.0316	CbGeAlD
Maprotiline—CHRM5—nervous system—Gilles de la Tourette syndrome	0.0013	0.0257	CbGeAlD
Maprotiline—CHRM4—brain—Gilles de la Tourette syndrome	0.00127	0.0251	CbGeAlD
Maprotiline—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.00125	0.0247	CbGeAlD
Maprotiline—SLC6A3—midbrain—Gilles de la Tourette syndrome	0.00108	0.0214	CbGeAlD
Maprotiline—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00105	0.0207	CbGeAlD
Maprotiline—CHRM5—brain—Gilles de la Tourette syndrome	0.000993	0.0196	CbGeAlD
Maprotiline—ORM1—nervous system—Gilles de la Tourette syndrome	0.000957	0.0189	CbGeAlD
Maprotiline—ORM1—central nervous system—Gilles de la Tourette syndrome	0.000921	0.0182	CbGeAlD
Maprotiline—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000892	0.0176	CbGeAlD
Maprotiline—SLC6A3—nervous system—Gilles de la Tourette syndrome	0.000889	0.0176	CbGeAlD
Maprotiline—HTR2C—nervous system—Gilles de la Tourette syndrome	0.00086	0.017	CbGeAlD
Maprotiline—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000859	0.017	CbGeAlD
Maprotiline—SLC6A3—central nervous system—Gilles de la Tourette syndrome	0.000856	0.0169	CbGeAlD
Maprotiline—HTR7—midbrain—Gilles de la Tourette syndrome	0.000841	0.0166	CbGeAlD
Maprotiline—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000828	0.0164	CbGeAlD
Maprotiline—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000812	0.0161	CbGeAlD
Maprotiline—DRD2—midbrain—Gilles de la Tourette syndrome	0.000795	0.0157	CbGeAlD
Maprotiline—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000782	0.0155	CbGeAlD
Maprotiline—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000727	0.0144	CbGeAlD
Maprotiline—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.000718	0.0142	CbGeAlD
Maprotiline—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.0007	0.0138	CbGeAlD
Maprotiline—HTR7—nervous system—Gilles de la Tourette syndrome	0.000692	0.0137	CbGeAlD
Maprotiline—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000691	0.0137	CbGeAlD
Maprotiline—CHRM2—brain—Gilles de la Tourette syndrome	0.000682	0.0135	CbGeAlD
Maprotiline—SLC6A3—brain—Gilles de la Tourette syndrome	0.00068	0.0134	CbGeAlD
Maprotiline—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000666	0.0132	CbGeAlD
Maprotiline—HTR2C—brain—Gilles de la Tourette syndrome	0.000657	0.013	CbGeAlD
Maprotiline—DRD2—nervous system—Gilles de la Tourette syndrome	0.000654	0.0129	CbGeAlD
Maprotiline—DRD2—central nervous system—Gilles de la Tourette syndrome	0.00063	0.0124	CbGeAlD
Maprotiline—CHRM1—brain—Gilles de la Tourette syndrome	0.000621	0.0123	CbGeAlD
Maprotiline—Atomoxetine—SLC6A3—Gilles de la Tourette syndrome	0.000588	0.102	CrCbGaD
Maprotiline—CHRM3—brain—Gilles de la Tourette syndrome	0.000555	0.011	CbGeAlD
Maprotiline—SLC6A2—brain—Gilles de la Tourette syndrome	0.000548	0.0108	CbGeAlD
Maprotiline—HTR7—brain—Gilles de la Tourette syndrome	0.000529	0.0105	CbGeAlD
Maprotiline—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000525	0.0104	CbGeAlD
Maprotiline—HRH1—nervous system—Gilles de la Tourette syndrome	0.000516	0.0102	CbGeAlD
Maprotiline—DRD2—brain—Gilles de la Tourette syndrome	0.0005	0.00988	CbGeAlD
Maprotiline—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000497	0.00983	CbGeAlD
Maprotiline—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000431	0.00853	CbGeAlD
Maprotiline—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000423	0.0736	CrCbGaD
Maprotiline—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000415	0.00821	CbGeAlD
Maprotiline—HRH1—brain—Gilles de la Tourette syndrome	0.000395	0.0078	CbGeAlD
Maprotiline—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000393	0.00777	CbGeAlD
Maprotiline—Nortriptyline—DRD2—Gilles de la Tourette syndrome	0.000382	0.0664	CrCbGaD
Maprotiline—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000378	0.00748	CbGeAlD
Maprotiline—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.000359	0.0624	CrCbGaD
Maprotiline—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000344	0.0068	CbGeAlD
Maprotiline—Atomoxetine—HTR2A—Gilles de la Tourette syndrome	0.000338	0.0588	CrCbGaD
Maprotiline—HTR2A—brain—Gilles de la Tourette syndrome	0.00033	0.00652	CbGeAlD
Maprotiline—Desipramine—DRD2—Gilles de la Tourette syndrome	0.000315	0.0547	CrCbGaD
Maprotiline—CYP2D6—brain—Gilles de la Tourette syndrome	0.0003	0.00594	CbGeAlD
Maprotiline—Nortriptyline—HTR2A—Gilles de la Tourette syndrome	0.000295	0.0513	CrCbGaD
Maprotiline—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000283	0.00559	CbGeAlD
Maprotiline—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000272	0.00538	CbGeAlD
Maprotiline—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000267	0.0464	CrCbGaD
Maprotiline—Desipramine—HTR2A—Gilles de la Tourette syndrome	0.000243	0.0423	CrCbGaD
Maprotiline—ABCB1—brain—Gilles de la Tourette syndrome	0.000216	0.00427	CbGeAlD
Maprotiline—Imipramine—HTR2A—Gilles de la Tourette syndrome	0.000206	0.0359	CrCbGaD
Maprotiline—CHRM5—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000174	0.00181	CbGpPWpGaD
Maprotiline—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00017	0.00176	CbGpPWpGaD
Maprotiline—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000169	0.00176	CbGpPWpGaD
Maprotiline—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000166	0.00172	CbGpPWpGaD
Maprotiline—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000165	0.00171	CbGpPWpGaD
Maprotiline—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000162	0.00168	CbGpPWpGaD
Maprotiline—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00016	0.00166	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000157	0.00163	CbGpPWpGaD
Maprotiline—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000156	0.00162	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000154	0.0016	CbGpPWpGaD
Maprotiline—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000154	0.00159	CbGpPWpGaD
Maprotiline—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000154	0.00159	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000153	0.00159	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00015	0.00155	CbGpPWpGaD
Maprotiline—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000149	0.00155	CbGpPWpGaD
Maprotiline—CHRM5—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000147	0.00152	CbGpPWpGaD
Maprotiline—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000146	0.00152	CbGpPWpGaD
Maprotiline—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000145	0.0015	CbGpPWpGaD
Maprotiline—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000142	0.00147	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000139	0.00145	CbGpPWpGaD
Maprotiline—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000139	0.00144	CbGpPWpGaD
Maprotiline—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000139	0.00144	CbGpPWpGaD
Maprotiline—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000135	0.0014	CbGpPWpGaD
Maprotiline—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000134	0.00139	CbGpPWpGaD
Maprotiline—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000132	0.00137	CbGpPWpGaD
Maprotiline—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000131	0.00136	CbGpPWpGaD
Maprotiline—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00013	0.00135	CbGpPWpGaD
Maprotiline—HTR7—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000129	0.00134	CbGpPWpGaD
Maprotiline—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000129	0.00134	CbGpPWpGaD
Maprotiline—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000127	0.00132	CbGpPWpGaD
Maprotiline—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000127	0.00131	CbGpPWpGaD
Maprotiline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000126	0.00131	CbGpPWpGaD
Maprotiline—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000126	0.00131	CbGpPWpGaD
Maprotiline—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000126	0.0013	CbGpPWpGaD
Maprotiline—HTR7—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000126	0.0013	CbGpPWpGaD
Maprotiline—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000125	0.0013	CbGpPWpGaD
Maprotiline—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000125	0.0013	CbGpPWpGaD
Maprotiline—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000125	0.00129	CbGpPWpGaD
Maprotiline—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000123	0.00128	CbGpPWpGaD
Maprotiline—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000123	0.00128	CbGpPWpGaD
Maprotiline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000123	0.00127	CbGpPWpGaD
Maprotiline—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000122	0.00127	CbGpPWpGaD
Maprotiline—CHRM4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000122	0.00127	CbGpPWpGaD
Maprotiline—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000122	0.00126	CbGpPWpGaD
Maprotiline—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000121	0.00126	CbGpPWpGaD
Maprotiline—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000121	0.00125	CbGpPWpGaD
Maprotiline—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00012	0.00124	CbGpPWpGaD
Maprotiline—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000119	0.00123	CbGpPWpGaD
Maprotiline—CHRM4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000119	0.00123	CbGpPWpGaD
Maprotiline—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000118	0.00122	CbGpPWpGaD
Maprotiline—CHRM5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000117	0.00121	CbGpPWpGaD
Maprotiline—HTR7—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000117	0.00121	CbGpPWpGaD
Maprotiline—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000115	0.00119	CbGpPWpGaD
Maprotiline—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000115	0.00119	CbGpPWpGaD
Maprotiline—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000114	0.00118	CbGpPWpGaD
Maprotiline—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000114	0.00118	CbGpPWpGaD
Maprotiline—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000114	0.00118	CbGpPWpGaD
Maprotiline—CHRM5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000114	0.00118	CbGpPWpGaD
Maprotiline—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000113	0.00117	CbGpPWpGaD
Maprotiline—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000113	0.00117	CbGpPWpGaD
Maprotiline—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000111	0.00115	CbGpPWpGaD
Maprotiline—CHRM4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00011	0.00115	CbGpPWpGaD
Maprotiline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000109	0.00113	CbGpPWpGaD
Maprotiline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000108	0.00113	CbGpPWpGaD
Maprotiline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000108	0.00112	CbGpPWpGaD
Maprotiline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000108	0.00112	CbGpPWpGaD
Maprotiline—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000108	0.00112	CbGpPWpGaD
Maprotiline—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000107	0.00111	CbGpPWpGaD
Maprotiline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000107	0.00111	CbGpPWpGaD
Maprotiline—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000107	0.00111	CbGpPWpGaD
Maprotiline—CHRM5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000106	0.0011	CbGpPWpGaD
Maprotiline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000106	0.0011	CbGpPWpGaD
Maprotiline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000105	0.00109	CbGpPWpGaD
Maprotiline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000105	0.00109	CbGpPWpGaD
Maprotiline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000105	0.00109	CbGpPWpGaD
Maprotiline—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000104	0.00108	CbGpPWpGaD
Maprotiline—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000104	0.00108	CbGpPWpGaD
Maprotiline—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000103	0.00107	CbGpPWpGaD
Maprotiline—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000103	0.00107	CbGpPWpGaD
Maprotiline—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000102	0.00105	CbGpPWpGaD
Maprotiline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.83e-05	0.00102	CbGpPWpGaD
Maprotiline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.81e-05	0.00102	CbGpPWpGaD
Maprotiline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.78e-05	0.00101	CbGpPWpGaD
Maprotiline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.75e-05	0.00101	CbGpPWpGaD
Maprotiline—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.73e-05	0.00101	CbGpPWpGaD
Maprotiline—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.65e-05	0.001	CbGpPWpGaD
Maprotiline—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.53e-05	0.000989	CbGpPWpGaD
Maprotiline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.28e-05	0.000963	CbGpPWpGaD
Maprotiline—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.26e-05	0.00096	CbGpPWpGaD
Maprotiline—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.26e-05	0.00096	CbGpPWpGaD
Maprotiline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.25e-05	0.00096	CbGpPWpGaD
Maprotiline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.22e-05	0.000957	CbGpPWpGaD
Maprotiline—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.62e-05	0.000895	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	8.43e-05	0.000874	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.41e-05	0.000873	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.28e-05	0.000859	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.26e-05	0.000857	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.24e-05	0.000854	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.21e-05	0.000852	CbGpPWpGaD
Maprotiline—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.19e-05	0.00085	CbGpPWpGaD
Maprotiline—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.17e-05	0.000847	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.17e-05	0.000847	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.13e-05	0.000843	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.04e-05	0.000834	CbGpPWpGaD
Maprotiline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.02e-05	0.000832	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.02e-05	0.000832	CbGpPWpGaD
Maprotiline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8e-05	0.000829	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.99e-05	0.000829	CbGpPWpGaD
Maprotiline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.97e-05	0.000827	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.97e-05	0.000827	CbGpPWpGaD
Maprotiline—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.93e-05	0.000823	CbGpPWpGaD
Maprotiline—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.89e-05	0.000819	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.89e-05	0.000819	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	7.87e-05	0.000817	CbGpPWpGaD
Maprotiline—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.74e-05	0.000803	CbGpPWpGaD
Maprotiline—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.49e-05	0.000777	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.47e-05	0.000775	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.45e-05	0.000773	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.42e-05	0.00077	CbGpPWpGaD
Maprotiline—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.41e-05	0.000769	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.35e-05	0.000763	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.31e-05	0.000758	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.1e-05	0.000736	CbGpPWpGaD
Maprotiline—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7e-05	0.000726	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.9e-05	0.000716	CbGpPWpGaD
Maprotiline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.87e-05	0.000713	CbGpPWpGaD
Maprotiline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.85e-05	0.000711	CbGpPWpGaD
Maprotiline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.83e-05	0.000708	CbGpPWpGaD
Maprotiline—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.76e-05	0.000701	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.7e-05	0.000695	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.64e-05	0.000689	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.61e-05	0.000686	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.61e-05	0.000686	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.44e-05	0.000668	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.42e-05	0.000666	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.27e-05	0.00065	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.24e-05	0.000648	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.08e-05	0.000631	CbGpPWpGaD
Maprotiline—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.04e-05	0.000627	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6e-05	0.000623	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6e-05	0.000623	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.98e-05	0.00062	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.83e-05	0.000604	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.67e-05	0.000588	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.43e-05	0.000563	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.39e-05	0.000559	CbGpPWpGaD
Maprotiline—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.33e-05	0.000553	CbGpPWpGaD
Maprotiline—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.23e-05	0.000543	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.23e-05	0.000543	CbGpPWpGaD
Maprotiline—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.22e-05	0.000541	CbGpPWpGaD
Maprotiline—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.2e-05	0.000539	CbGpPWpGaD
Maprotiline—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.15e-05	0.000534	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	4.99e-05	0.000518	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.89e-05	0.000508	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.87e-05	0.000506	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.76e-05	0.000493	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.75e-05	0.000493	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	4.71e-05	0.000488	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.68e-05	0.000485	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.67e-05	0.000484	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.65e-05	0.000483	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.64e-05	0.000481	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.63e-05	0.00048	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.62e-05	0.000479	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.59e-05	0.000477	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.54e-05	0.000471	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.53e-05	0.00047	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.52e-05	0.000469	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.5e-05	0.000467	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.46e-05	0.000463	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.43e-05	0.000459	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.37e-05	0.000454	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.32e-05	0.000448	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.25e-05	0.000441	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.24e-05	0.00044	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.23e-05	0.000439	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.23e-05	0.000438	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.22e-05	0.000438	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.21e-05	0.000437	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.21e-05	0.000437	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.2e-05	0.000436	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.2e-05	0.000435	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.19e-05	0.000435	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.19e-05	0.000434	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.17e-05	0.000433	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.15e-05	0.000431	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.13e-05	0.000428	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.12e-05	0.000427	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.1e-05	0.000426	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.09e-05	0.000424	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.05e-05	0.00042	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	3.99e-05	0.000414	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.97e-05	0.000412	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.92e-05	0.000407	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.84e-05	0.000399	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.83e-05	0.000398	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.82e-05	0.000397	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.81e-05	0.000395	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.81e-05	0.000395	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.8e-05	0.000394	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.77e-05	0.000391	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	3.71e-05	0.000385	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.7e-05	0.000384	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.59e-05	0.000373	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.55e-05	0.000368	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.55e-05	0.000368	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.44e-05	0.000357	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.41e-05	0.000354	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.35e-05	0.000347	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.21e-05	0.000333	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.1e-05	0.000322	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.01e-05	0.000312	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.96e-05	0.000307	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.95e-05	0.000306	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.94e-05	0.000305	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.91e-05	0.000302	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.89e-05	0.0003	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.81e-05	0.000291	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.74e-05	0.000284	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.69e-05	0.000279	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.68e-05	0.000278	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.67e-05	0.000277	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.64e-05	0.000274	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.61e-05	0.000271	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.55e-05	0.000265	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.51e-05	0.00026	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.5e-05	0.00026	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.5e-05	0.000259	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.49e-05	0.000258	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.48e-05	0.000258	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.48e-05	0.000257	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.46e-05	0.000256	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.44e-05	0.000253	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.43e-05	0.000252	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.42e-05	0.000251	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.42e-05	0.000251	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.39e-05	0.000248	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.35e-05	0.000243	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.27e-05	0.000235	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.27e-05	0.000235	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.26e-05	0.000234	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.25e-05	0.000233	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.25e-05	0.000233	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.23e-05	0.000231	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.00019	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.62e-05	0.000168	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.59e-05	0.000165	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.58e-05	0.000164	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.58e-05	0.000164	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.56e-05	0.000162	CbGpPWpGaD
